Their persistence and wide consumption identify pharmaceuticals as ''emerging pollutants''.
INTRODUCTION
Pharmaceuticals (substances used in human and veterinary medicine) are produced and used in permanently increasing amounts worldwide. However, after their uncontrolled release into the environment they may cause environmental pollution as has been stressed in several recent studies (Heberer 2002; Calamari et al. 2003; Weigel et al. 2004; Fent et al. 2006) . Pharmaceuticals are designed to have a specific mode of action, and many of them are persistent with respect to metabolism in the body, after their release into the environment and even after treatment of wastes. The possible environmental impact of pharmaceuticals is characterized by their significant consumption and by the large number of active substances produced. In the European Union about 3000 different substances are used in human and veterinary medicine, the major groups being substances such as analgesics and antiinflammatory drugs, contraceptives, antibiotics, beta-blockers, lipid regulators, neuroactive compounds, anticancer drugs and many others (Fent et al. 2006; Cunningham et al. 2009 ). The persistence of these pharmaceuticals makes them ''emerging pollutants'' and stresses the need to advance waste and wastewater treatment technologies in addition to studying their potential effects in aquatic environments (Richardson & Ternes 2005) . It has been found that the load of pharmaceuticals can be compared with pesticide loads (Comoretto & Chiron 2005) . Unless the acute toxicity of pharmaceuticals is low, information about chronic effects in the environment is often scarce. In many studies, residues of pharmaceuticals at trace quantities have been found to be widespread in aquatic environments (Calamari et al. 2003; Hernando et al. 2006; Kim et al. 2008) .
Among the main factors influencing the fate of pharmaceuticals in sludges, soil and the aquatic environment may be their interaction with humic substances. Humic substances (HS) are the most widely found naturally occurring organic substances (Stevenson 1994) . Humic substances are a general category of naturally occurring, biogenic, heterogeneous organic substances that can generally be characterized as being yellow to black in color, of high molecular weight and refractory. Humic substances can be divided in three fractions: a) humin is the fraction of humic substances that is not soluble in water at any pH; b) humic acid (HA) is the fraction of humic substances that is not soluble in water under acidic conditions (below pH 2), but becomes soluble at greater pH; c) fulvic acid is the fraction of humic substances that is soluble under all pH conditions (Stevenson 1994) . Humic substances form most of the organic component of soil, peat and natural waters, they influence the process of fossil fuel formation, and play a major role in the global carbon geochemical cycle. The interaction of humic substances with xenobiotics may modify the uptake and toxicity of these compounds, and affect the fate of pollutants in the environment (Karthikeyan & Chorover 2002; Nakashima et al. 2007) . The structure of humic substances is characterized by the presence of numerous aromatic, carboxylic and phenolic functionalities, linked together with alkyl moieties, imparting a measure of flexibility to the polymer chains (Leenheer 2007) .
Considering the wide application of some drugs, it may be particularly important to study drugs containing tricyclic structures (adamantane derivatives), such as Rimantadine (widely used in the prophylaxis and treatment of flu epidemics), Memantine (efficient in the treatment of Alzheimer's and Parkinson's disease), Tromantadine and many others. Substitutions at various locations on the ring will determine the pharmacokinetics and biotransformation which could contribute to the overall activity including side effects (Hoffman 1980) . Adamantane ring-containing substances, such as Rimantadine, are extraordinarily stable compounds, thus the study of their fate in the environment could be of high importance during intensive use, for example, during flu epidemics which may result in high concentrations in the environment. It was found that the full antiviral activity of Rimantadine was retained following extended storage (25 years) at room temperature, at 41C for 20 years and in solutions subjected to various elevated temperatures including boiling (Scholtisek & Webster 1998) .
The objective of the present study was to investigate the character of and factors controlling interactions between pharmaceuticals, especially those containing adamantane structures, their precursors and humic substances.
MATERIALS AND METHODS

Materials
Analytical quality reagents (Merck Co., Sigma-Aldrich Co., Fluka Chemie AG RdH Laborchemikalien GmbH Co.) were used without further purification. All chemicals used in this study were of high purity (usually ''suprapure'' grade unless otherwise stated). For the preparation of solutions, high purity water Millipore Elix 3 (Millipore Co.) 10-15 MO/cm was used throughout.
The studied pharmaceuticals and their precursors as high purity active substances were obtained from their manufacturers. Rimantadine hydrochloride (Rimantadine or amethyl-l-adamantanemethylamine hydrochloride), 2-aminoadamantane hydrochloride and 1-hydroxyadamantane were used in this research. To compare the interaction between adamantine group containing pharmaceuticals and humic substances also other structurally differing substances were used: Phenibut (4-amino-3-phenyl-butanoic acid hydrochloride), 3-aminoquinuclidine dihydrochloride. Carbamazepine was purchased from Sigma-Aldrich Co. The properties of the studied pharmaceuticals are summarized in Table 1 .
Isolation of humic substances
Humic acids from Gagu bog (Latvia) peat were extracted and purified using procedures recommended by the International Humic Substances Society (IHSS) (Tan 2005) . Briefly, 20 g of air-dried and finely ground samples were extracted under N 2 with 1 liter of 1 M NaOH and stirred for 24 h. The suspension was filtered and the solution was acidified with conc. HCl to pHo2 to precipitate humic acids, leaving fulvic acids in solution. The obtained humic acids were further purified by repeatedly dissolving and precipitating as well as dialyzing against Millipore water with final drying. Humic acids from waters of the River Daugava (Latvia) were obtained as suggested by Thurman & Malcolm (1981) : humic acids were sorbed onto XAD-8 resin, cleaned, then eluted with 0.05 M NaOH, desalted by lyophylisation and freeze dried. Humic acids were purchased from Sigma-Aldrich Co (Aldrich HA) and the International Humic Substances Society (Leonardite HA, Pahokee HA, Waskish HA). The properties of the studied humic substances are as reported in Table 2 .
Characterization of humic substances
Elemental analysis (C, H, N, S, and O) was carried out using an Elemental Analyzer Model EA-1108 (Carlo Erba Instruments). UV/Vis spectra were recorded on a Thermospectronic Helios g UV (Thermo Electron Co.) spectrophotometer in a 1-cm quartz cuvette. An automatic titrator TitroLine easy (Schott-Gerä te GmbH) was used to measure carboxylic and total acidity of each HA. The known Ca-acetate method (Tan 2005) , based on the formation of acetic acid, was used for determination of the total amount of carboxylic groups.
HA (20 mg) was weighed in a 100 ml Erlenmeyer flask and under N 2 10 ml of 0.2 N calcium acetate solution was added. Samples were potentiometrically titrated to pH 9.0 with 0.1 N NaOH. To estimate total acidity (Tan 2005) , a known amount of humic acid, about 20 mg, was dispersed in 10 ml of 0.1 M Ba(OH) 2 solution, which was then shaken overnight under N 2 , filtered and washed with water. The filtrate together with the washing solution was potentiometrically titrated with 0.1 M HCl to pH 8.4 under N 2 flow.
All pharmaceutical solutions were made in phosphate buffer (0.077 M, pH 7). A stock solution of 1-hydroxyadamantane was obtained using 10 ml of ethanol, because of its poor solubility in water. Stock solution concentrations of pharmaceuticals were 1 mmol/l. Solutions of Aldrich and Pahokee HA were obtained by the addition of phosphate buffer, however, Gagu HA was dissolved in 0.1 N NaOH and then diluted to the necessary concentration. Aliquots of the stock solutions of HS and pharmaceuticals were mixed 1:1. Final concentrations of HA were 5 mg/l, 10 mg/l, 15 mg/l, 20 mg/l, 25 mg/l, 30 mg/l, 35 mg/l, 40 mg/l and 50 mg/l. The solution of HS and pharmaceuticals was poured into a quartz cell. The fluorescence spectra were determined on a spectrofluorometer Perkin Elmer LS55 at room temperature (251C). The SSFS (synchronous-scan fluorescence spectroscopy) results were recorded at a speed of 250 nm/min, at a constant offset (Dl ¼ 25 nm) between excitation and emission wavelengths, 10 nm (Ex) and 10 nm (Em) slit widths.
Influence of pH on interactions of HA-pharmaceuticals
Aldrich, Pahokee, or Waskish HA were dissolved in 0.1 N NaHCO 3 (final concentration of HA was 25 mg/l) and mixed with the stock solution of Rimantadine to reach a final concentration of pharmaceutical (0.5 mmol/l). pH values were adjusted to fixed values from pH 2.7 to pH 9.2 with 0.1 N HCl. Conditions for fluorescence analyses were as previously mentioned.
Influence of ionic strength on interactions of HA -pharmaceuticals
Binding sites of humic substances were investigated using a solution of HA, pharmaceuticals and NaNO 3 so that the concentrations of NaNO 3 were 1 mol/l, 0.75 mol/l, 0.5 mol/l, 0.25 mol/l, 0.1 mol/l and 0.05 mol/l, while the final concentrations of HA were 25 mg/l and the pharmaceuticals were 0.5 mmol/l. Solutions were well mixed and SSFS was then performed.
Investigation of HA-pharmaceutical interaction kinetics
Solutions of pharmaceuticals in phosphate buffer (pH 7.2) and a solution of HA in 0.1 N NaOH were prepared and aliquots of both stock solutions were mixed 1:1. The final concentration of the pharmaceuticals was 0.5 mmol/l, and HA was 25 mg/l. For these measurements, SSFS spectra were taken for 10 min and each measurement has been made after 1 min. Emission spectra were recorded at 500 nm/min, scan ranges were from 350 nm to 600 nm and excitation was at 350 nm.
Study of interactions between humic substances and pharmaceuticals depending on molecular mass of humic substances
To study the interactions between humic substances and pharmaceuticals, the Gagu bog peat HA (initial concentration 1 g/l, pH 6) was fractionated using Amicon Ultra -4 filters (Millipore) with pore size corresponding to molecular masses 100, 50, 30, 10 and 5 kDa using a centrifuge (Wifug Labor-M, rotation speed 4500 rpm). In each of the obtained fractions the total organic carbon concentration was determined (TOC, VCSN Shimadzu) and the synchronous scan fluorescence spectra were recorded for each corresponding fraction of Gagu HA and the studied pharmaceuticals (final concentration in the solution 0.5 mmol/l, pH 7.0).
RESULTS AND DISCUSSION
As a tool to study complex formations with humic substances, fluorescence spectroscopic methods (fluorescence quenching due to complex formation) is used in our study as far as this method is a simple, quick and reliable avoiding the complicated separation of the complex from individual substances (Peuravuori 2001) . The synchronous-scan fluorescence excitation emission spectra of humic substances are shown in Figure 1 and they differ significantly depending on the origin of the humic acids: spectra of highly humified HAs (IHSS reference humic acids: Leonardite HA, Pahokee peat HA, as well as the industrially produced Aldrich HA) were characterized by two major fluorescence peaks. Aquatic humic acid isolated from water of the River Daugava was characterized by one peak (~375 nm), but peat humic acid (isolated from Gagu sphagnum bog peat) was characterized by two peaks (~345 and 375 nm). Synchronous scan spectra of humic substances isolated from highly humified organic material (leonardite, coal) had an intensive fluorescence peak 475 nm that was determined by the presence of conjugated unsaturated bond systems bearing carbonyl and carboxyl groups (substituting aromatic core structures), but its intensity differed with respect to aromaticity of the humic acid selected (Peuravuori et al. 2002) . This behaviour may be related to the low degree of aromaticity as found in our previously using 13 C NMR (Peuravuori 2001) .
Synchronous-scan fluorescence spectra of the studied pharmaceuticals significantly differed from those of humic substances (Figures 2 and 3 ) and with the exception of 4-amino-3-phenyl-butanoic acid and Carbamazepine they did not exhibit significant fluorescence intensity in the spectral regions common for humic acids.
The synchronous-scan fluorescence spectra of the studied pharmaceuticals in the presence and absence of humic acids demonstrated quenching of the fluorescence peak~272 nm (Figure 4) . Thus, the fluorescence quenching methodology in our study differs from the approach used to study interaction between humic acids and metal ions (Alberts & Takacs 2004) and Carbamazepine (Bai et al. 2008) . As far as this case is concerned, the fluorophore structures in the pharmaceuticals molecules were quenched and the humic substances were the quencher. In this respect the interaction between humic acids is similar to that with polyaromatic hydrocarbons (Karthikeyan & Chorover 2002) and such an approach supports the interaction analysis between humic substances and a large number of substances of interest. The uorescence intensities of peaks at~272 nm exhibited a successive decrease as the concentrations of the studied humic substances increased (Figure 4) . The fluorescence maxima peaks were slightly shifted towards the shorter wavelengths. This may be attributed to the different modifications of the fluorophoric structures in pharmaceutical and humic molecules during the interaction between humic acids and pharmaceuticals. This may indicate the preferential binding of highly hydrophobic adamantine-containing pharmaceuticals, but especially their precursors (such as 1-hydroxyadamantane) to more hydrophobic structures, with consecutive changes in the conformation of humic macromolecules. If amino groups play an important role in the binding process (as in the case of Rimantadine or 2-aminoadamantane as well as 4-amino-3-phenyl-butanoic acid molecules) the character of the interaction differs significantly.
The intensity of the fluorescence quenching is supposed to be proportional to the concentration of the formed humicpharmaceutical complex according to the Stern-Volmer equation (Gauthier et al. 1986) . The fluorescence of the pharmaceuticals quenching mechanism by humic acids is considered in the 1:1 interaction model (Bai et al. 2008) . The binding constants K b are obtained by steady-state fluorescence quenching measurements at wavelength 271.5 nm and are given as a slope in the Stern-Volmer plot and can be calculated estimating I 0 /I -fluorescence intensity ratio of the initial substance (I 0 ) and fluorescence in the presence of quencher (I).
The character of the relationships from modied SternVolmer plots ( Figure 5 ) offer strong support for the 1:1 complex (r 2 40.99). Fluorescence quenching of 4-amino-3-phenyl butanoic acid, 1-hydroxyadamantane and 2-aminoadamantane by dissolved humic acid was described by nonlinear Stern-Volmer plots. If the linear Stern-Volmer plot is indicative of a single class of fluorophores with equal accessibility to the quencher, then a combination of dynamic and static quenching typically produces a nonlinear SternVolmer plots (Gadad et al. 2007 ) as we found in our case. The calculated K b , values for different humic acids and pharmaceuticals are shown in Table 3 . The lowest log K b value was 3.17 l/mol. Therefore, it is possible that the primary quenching process during the interaction between the studied pharmaceuticals and HA was the static mechanism. The fact that the curve calculated from the nonlinear Stern-Volmer equation fitted the experimental data well ( Figure 5 ) provides further support for the combination of the dynamic and static quenching process and the 1:1 model. Log K ranged from 3.17 to 6.62 l/ mol for the studied pharmaceuticals. The observed log K b value for the interaction between Carbamazepine and Gagu humic acid (log K b ¼ 4.87 l/mol) was in good agreement with the value found in a previous study (log K b ¼ 3.41-5.04 l/mol) (Bai et al. 2008) using landfill leachate humic acid. Strong binding was found in the case of the interaction between Gagu HA and 4-amino-3-phenylbutanoic acid. In this case the formation of the complex may be determined not only by hydrophobicity, but also by salt formation between corresponding functional groups in humic acid and pharmaceuticals.
In previous studies an increased association of polycyclic aromatic compounds with dissolved HA was found with increasing pH of the solutions and has been associated with the degree of aromaticity of the interacting substances (Gauthier et al. 1986) , stressing the role of hydrophobic interactions between humic substances and pharmaceuticals. The plot of dependence of I 0 /I on pH for the studied humic acids and Rimantadine (Figure 6 ) confirms the same mode of interaction. As seen in Table 3 substances bearing amino groups had a significantly larger binding constant among the studied pharmaceuticals and their precursors. This fact suggests that an electrostatic interaction plays a dominant role in the binding between the studied pharmaceuticals and HA, because Rimantadine, 2-aminoadamantane hydrochloride and 3-aminoquinuclidine dihydrochloride had a positive charge and HA had a negative charge. The predominant role of electrostatic interactions is also implied by the fact that 1-hydroxyadamantane had the smallest binding constant. In order to confirm the importance of electrostatic interactions in the binding between Rimantadine and HA interaction depend on ionic strength and with increasing ionic strength the fluorescence quenching significantly decreased. Therefore it is evident that the interaction between the studied pharmaceuticals and HA was dominated by electrostatic forces. Other evidence for this assumption was the observed good correlation between the binding constants and carboxyl group concentrations in the interactions between humic acids and Rimantadine, and a much poorer correlation in the case of 1-hydroxyadamantane (Figure 7) . The binding constants thus obtained are summarized in Table 3 .
The interactions between the studied pharmaceuticals and humic acids largely depended on the molecular mass of the latter (Figure 8 ). It can be seen from Figure 8 that the fluorescence quenching intensity (complex formation between the studied pharmaceutical and humic substance) significantly increased with the molecular mass of humic substances and this increase was highest for 4-amino-3-phenyl butanoic acid, and lowest for 1-hydroxyadamantane. It is possible that this effect may be associated with two interaction mechanisms -dominance of more hydrophobic elements in the structure of humic substances with increasing molecular weight, however, at the same time an interaction with stoichiometry of a higher order than 1:1 complex formation is highly possible.
CONCLUSIONS
We have determined the binding constants between HA and selected pharmaceuticals using a fluorescence quenching technique. Of the studied adamantine group of pharmaceuticals and their precursors, it was found that Rimantadine had a significantly larger binding constant than its precursors. This difference is explained by electrostatic interactions between HA and the studied pharmaceuticals, because those with higher binding properties (Rimantadine, 3-aminoquinuclidine, 2-aminoadamantane) are cationic while humic acids are anionic. Our findings suggest that an electrostatic interaction plays a dominant role in the complex formation between humic acids and pharmaceuticals. The importance of the electrostatic attraction between humic acids and pharmaceuticals was also confirmed by a salt effect and pH dependence of the fluorescence quenching effect. The electrostatic interaction between cationic pharmaceuticals and HA was weakened at low pH, resulting in a decrease in the binding constants. The results of this study support the development of an understanding of the fate of pharmaceuticals in the environment as well as the development of analytical methods for pharmaceuticals in waters and medical wastewater treatment approaches.
